In focus · trending topic

Peter Greenleaf

10 stories · following the connections

Sucampo Pharmaceuticals Announces its Participation at the Global Mizuho Investor Conference

By Nasdaq OMXNov 27, 2017, 9:10 PM UTC

Sucampo to Host 2017 R&D Day on November 16 in New York

By Nasdaq OMXNov 9, 2017, 10:48 PM UTC

Sucampo Pharmaceuticals Announces FDA Acceptance of sNDA for AMITIZA in Children with Pediatric Functional Constipation, with Priority Review Designation

By Nasdaq OMXSep 28, 2017, 9:34 PM UTC

Sucampo Reports Second Quarter 2017 Financial Results

By Nasdaq OMXAug 2, 2017, 10:30 AM UTC

Sucampo Acquires Vtesse Inc.

By Nasdaq OMXApr 3, 2017, 10:30 AM UTC

Sucampo Reports Fourth Quarter and Full Year 2016 Financial Results

By Nasdaq OMXMar 8, 2017, 11:30 AM UTC

Sucampo Announces Fourth Quarter and Full Year 2016 Earnings Call

By Nasdaq OMXFeb 23, 2017, 9:02 PM UTC

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Leerink Global Healthcare Conference

By Nasdaq OMXFeb 9, 2017, 11:30 AM UTC